Liver transplantation for patients with hepatitis B: Prevention of hepatitis B recurrence by intravenous AntiHepatitis B immunoglobulin and lamivudine

被引：20

作者：

Lee, PH

Hu, RH

Tsai, MK

Ho, MC

Lai, HS

Lai, MY

Yang, PM

机构：

[1] Natl Taiwan Univ, Coll Med, Dept Surg, Taipei, Taiwan

[2] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan

来源：

TRANSPLANTATION PROCEEDINGS | 2000年 / 32卷 / 07期

关键词：

D O I：

10.1016/S0041-1345(00)01653-5

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：2245 / 2247

页数：3

共 7 条

[1]

[Anonymous], J FORMOS MED ASS

[2] Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation [J].

Bartholomew, MM ;

Jansen, RW ;

Jeffers, LJ ;

Reddy, KR ;

Johnson, LC ;

Bunzendahl, H ;

Condreay, LD ;

Tzakis, AG ;

Schiff, ER ;

Brown, NA .

LANCET, 1997, 349 (9044) :20-22

[3] A one-year trial of lamivudine for chronic hepatitis B [J].

Lai, CL ;

Chien, RN ;

Leung, NWY ;

Chang, TT ;

Guan, R ;

Tai, DI ;

Ng, KY ;

Wu, PC ;

Dent, JC ;

Barber, J ;

Stephenson, SL ;

Gray, DF .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (02) :61-68

[4] Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin [J].

Markowitz, JS ;

Martin, P ;

Conrad, AJ ;

Markmann, JF ;

Seu, P ;

Yersiz, H ;

Goss, JA ;

Schmidt, P ;

Pakrasi, A ;

Artinian, L ;

Murray, NGB ;

Imagawa, DK ;

Holt, C ;

Goldstein, LI ;

Stribling, R ;

Busuttil, RW .

HEPATOLOGY, 1998, 28 (02) :585-589

[5]

SAMUEL D, 1998, NEW ENGL J MED, V329, P842

[6] Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization [J].

Sawyer, RG ;

McGory, RW ;

Gaffey, MJ ;

McCullough, CC ;

Shephard, BL ;

Houlgrave, CW ;

Ryan, TS ;

Kuhns, M ;

McNamara, A ;

Caldwell, SH ;

Abdulkareem, A ;

Pruett, TL .

ANNALS OF SURGERY, 1998, 227 (06) :841-847

[7] Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin [J].

Terrault, NA ;

Zhou, S ;

Combs, C ;

Hahn, JA ;

Lake, JR ;

Roberts, JP ;

Ascher, NL ;

Wright, TL .

HEPATOLOGY, 1996, 24 (06) :1327-1333

← 1 →